Total Optical Coherence Characterization for Automated Tumor Analysis

Developing novel optical imaging systems to non-destructively characterize glioblastoma tissue and identify tumor spheroids that accurately mimic original tumors for personalized treatment testing.

Subsidie
€ 1.494.125
2025

Projectdetails

Introduction

Drug resistance, whether intrinsic or acquired during the course of treatment, is the primary cause of cancer treatment failure. Resistance is a complex and highly personalized problem, depending on tumor-specific, genetic, and other factors, but certain cancers are particularly difficult to treat.

Glioblastoma

In particular, the most common and deadliest type of cancer originating in the brain, glioblastoma (GBM), is aggressive and highly resistant to treatment. Due to the complex nature of GBM, advanced methods for screening personalized treatment strategies are critically needed to improve patient outcomes.

Cell Spheroids

Cell spheroids are 3D tissue cultures that have proven to be a more accurate model of tumor tissue for therapeutic testing. However, they are sensitive to their growth and preparation conditions. Variability in spheroid properties may affect the results of therapeutic testing, so a method of identifying spheroids with properties that match the original tissue is needed.

Proposed Solution

In order to combat GBM and other drug-resistant cancers, we propose the development of two novel optical imaging systems. These systems will perform non-destructive characterization of tumor tissue and live monitoring of in vitro drug testing on tumor spheroids.

Imaging System Design

Both imaging systems use a unique design to scan the tissue samples at different angles to quantify a wide range of optical properties within the tissue with 3D micron scale resolution. This approach integrates several different optical coherence tomography-based methods and addresses their weaknesses to create a unique platform for comprehensive measurements of optical properties.

Application

This platform will be used to scan the original tumor tissue and the resulting tumor spheroids to identify which spheroids will most reliably mimic the original tumor tissue for testing different therapeutic interventions.

Conclusion

This approach has the potential to advance the field of personalized medicine and enable more rapid and reliable development of cancer therapies.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.494.125
Totale projectbegroting€ 1.494.125

Tijdlijn

Startdatum1-6-2025
Einddatum31-5-2030
Subsidiejaar2025

Partners & Locaties

Projectpartners

  • MEDIZINISCHE UNIVERSITAET WIENpenvoerder

Land(en)

Austria

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860

Vergelijkbare projecten uit andere regelingen

ERC COG

Deciphering and targeting cellular states in glioblastoma

This project aims to explore and target the cellular heterogeneity in glioblastoma by characterizing common and novel cellular states through advanced sequencing and treatment strategies.

€ 2.000.000
ERC COG

Tumor recurrence and therapeutic resistance: exploring and exploiting the post-radiotherapy brain microenvironment for therapeutic opportunities in malignant brain tumors

This project aims to target the irradiated microenvironment of recurrent glioblastoma by integrating advanced sequencing methods and high-throughput screening to discover novel therapeutic strategies.

€ 1.999.444
ERC POC

A Real-time imaging and classification system for low-grade glioma detection during brain surgery

This project aims to develop a real-time imaging tool for neurosurgeons to accurately identify low-grade glioma tissue during surgery, enhancing tumor removal and improving patient outcomes.

€ 150.000
ERC COG

Deciphering Cancer Heterogeneity and Drug resistance using Single-Clone Genomic and Epigenomic Landscapes

This project aims to develop innovative single-cell technologies to analyze tumor subclones, enhancing understanding of drug resistance and identifying new therapeutic targets in brain cancers.

€ 2.000.000